help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mannor, D. A.
Right arrow Articles by Baumann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mannor, D. A.
Right arrow Articles by Baumann, G.

Journal of Clinical Endocrinology & Metabolism, Vol 73, 30-34, Copyright © 1991 by Endocrine Society


ARTICLES

Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action

DA Mannor, LM Winer, MA Shaw and G Baumann
Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

GH-binding proteins (GH-BP) have recently been discovered in human plasma, but their biological function is unknown. The high affinity GH- BP is related to the GH receptor and may modulate the interaction of GH with tissue receptors, whereas the low affinity GH-BP should be inert in this regard. Modulation of receptor binding probably results in modulation of GH bioactivity. To address these issues, we examined the effects of purified GH-BPs as well as whole plasma on GH binding to receptors in human, rabbit, and female rat liver and in rat adipocytes. High affinity BP inhibited binding of GH to receptors in a dose- dependent fashion. Substantial inhibition was observed within the physiological range of BP concentrations; human liver and rat adipocytes were the most sensitive in this regard. In contrast, the low affinity BP had no effect on receptor binding of GH. Whole human plasma also inhibited GH binding to receptors. This effect could be attributed to its content of GH-BP, since removal or primary absence of the BP from plasma abolished its inhibitory effect. Purified high affinity BP also inhibited GH-dependent insulin-like growth factor-I production by cultured human fibroblasts to a degree comparable to receptor inhibition. We conclude that the circulating high affinity GH-BP, by sequestering GH, substantially interferes with binding of GH to its receptor, and that the well known inhibitory effect of plasma in RRAs for GH is largely due to this BP. GH action in human fibroblasts in vitro is similarly inhibited by this BP.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. Frystyk, C. M. Andreasen, and S. Fisker
Determination of Free Growth Hormone
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3008 - 3014.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Wang, K. He, M. Gerhart, J. Jiang, R. J. Paxton, R. K. Menon, R. A. Black, G. Baumann, and S. J. Frank
Reduced Proteolysis of Rabbit Growth Hormone (GH) Receptor Substituted with Mouse GH Receptor Cleavage Site
Mol. Endocrinol., October 1, 2003; 17(10): 1931 - 1943.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Wolthers, D. M. Hoffman, A. G. Nugent, M. W Duncan, M. Umpleby, and K. K. Y. Ho
Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1191 - E1196.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Zhang, J. Jiang, R. A. Black, G. Baumann, and S. J. Frank
Tumor Necrosis Factor-{{alpha}} Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation
Endocrinology, December 1, 2000; 141(12): 4342 - 4348.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B.-A. Bengtsson and G. Johannsson
The Treatment of Growth Hormone Deficiency in Adults
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 933 - 937.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. D. McIntyre, R. Serek, D. I. Crane, T. Veveris-Lowe, A. Parry, S. Johnson, K. C. Leung, K. K. Y. Ho, M. Bougoussa, G. Hennen, et al.
Placental Growth Hormone (GH), GH-Binding Protein, and Insulin-Like Growth Factor Axis in Normal, Growth-Retarded, and Diabetic Pregnancies: Correlations with Fetal Growth
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1143 - 1150.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Rui, S. F. Archer, L. S. Argetsinger, and C. Carter-Su
Platelet-derived Growth Factor and Lysophosphatidic Acid Inhibit Growth Hormone Binding and Signaling via a Protein Kinase C-dependent Pathway
J. Biol. Chem., January 28, 2000; 275(4): 2885 - 2892.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K.-C. Leung, N. Doyle, and K. K. Y. Ho
Characterization of a Low Affinity Binding Protein for Growth Hormone in Rat Serum
Endocrinology, January 1, 2000; 141(1): 138 - 145.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Edens and F. Talamantes
Alternative Processing of Growth Hormone Receptor Transcripts
Endocr. Rev., October 1, 1998; 19(5): 559 - 582.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. P. Frick, L.-R. Tai, W. R. Baumbach, and H. M. Goodman
Tissue Distribution, Turnover, and Glycosylation of the Long and Short Growth Hormone Receptor Isoforms in Rat Tissues
Endocrinology, June 1, 1998; 139(6): 2824 - 2830.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Andersen, P. H. Petersen, O. Blaabjerg, J. Hangaard, and C. Hagen
Evaluation of growth hormone assays using ratio plots
Clin. Chem., May 1, 1998; 44(5): 1032 - 1038.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Alele, J. Jiang, J. F. Goldsmith, X. Yang, H. G. Maheshwari, R. A. Black, G. Baumann, and S. J. Frank
Blockade of Growth Hormone Receptor Shedding by a Metalloprotease Inhibitor
Endocrinology, April 1, 1998; 139(4): 1927 - 1935.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K.-C. Leung and K. K. Y. Ho
Stimulation of Mitochondrial Fatty Acid Oxidation by Growth Hormone in Human Fibroblasts
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4208 - 4213.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Tzanela, C. Wagner, and G. Shaffer Tannenbaum
Recombinant Human Growth Hormone-Binding Protein Fails to Enhance the in Vivo Bioactivity of Human Growth Hormone in Normal Rats
Endocrinology, December 1, 1997; 138(12): 5316 - 5324.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. I. Ymer, J. L. Stevenson, and A. C. Herington
Guinea Pig Serum Contains a Specific High Affinity Growth Hormone-Binding Protein with Novel Ligand Specificity
Endocrinology, September 1, 1997; 138(9): 3577 - 3586.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Kline and C. V. Clevenger
Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk
J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, R. Guan, J. Jiang, J. J. Kopchick, R. A. Black, G. Baumann, and S. J. Frank
Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis
J. Biol. Chem., June 29, 2001; 276(27): 24565 - 24573.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society